Showing results (41-50 of 270) with videos related to
Sort By:
Pageof 27
Thoracic Surgery Clinics|April 24, 2012
The impact of chemotherapy on the lymphatic system in thoracic oncologyAntonio Passaro, Patrizia Trenta, Davide Conte, et al.Clinical Lung Cancer|June 24, 2014
management of nonhematologic toxicities associated with different EGFR-TKIs in advanced NSCLC: a comparison analysisAntonio Passaro, Massimo Di Maio, Ester Del Signore, et al.Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafishXiuning Le, David M Langenau, Matthew D Keefe, et al.Nature Reviews. Clinical Oncology|November 29, 2024
The changing treatment landscape of EGFR-mutant non-small-cell lung cancerFei Zhou, Haoyue Guo, Yang Xia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2020
Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR MutationsAntonio Passaro, Tony Mok, Solange Peters, et al.Journal for Immunotherapy of Cancer|March 19, 2021
Severity of COVID-19 in patients with lung cancer: evidence and challengesAntonio Passaro, Christine Bestvina, Maria Velez Velez, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2017
Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung AdenocarcinomaDeepa Rangachari, Paul A VanderLaan, Meghan Shea, et al.Lung Cancer (Amsterdam, Netherlands)|April 3, 2026
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerabilityGerrina Ruiter, Xiuning Le, Ross A Soo, et al.NPJ Precision Oncology|July 2, 2025
Progress and challenges of artificial intelligence in lung cancer clinical translationErjia Zhu, Amgad Muneer, Jianjun Zhang, et al.Lung Cancer (Amsterdam, Netherlands)|July 18, 2026
Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOTFilippo de Marinis, Tina Cascone, Patrick M Forde, et al.Pageof 27